AIP Corporation (HQ: Tokyo, Shibuya Ward, CEO: Hidefumi Watanabe URL:　http://www.aip-global.com/ hereafter referred to as “AIP”）and M3, Inc. (HQ：Tokyo, Minato Ward, CEO：Itaru Tanimura URL：http://corporate.m3.com/ hereafter referred to as “M3”), have at this time announced the formation of a capital and business alliance in a step towards teaming together to deliver global healthcare research centered in emerging Asian countries.

AIP offers survey panels reaching consumers in over 45 countries. (AIP proprietary panels cover 15 countries/regions.) With offices in 6 countries and regions, primarily in Asia, AIP achieves survey results for more than 2000 projects every year for clients from more than 18 countries worldwide.

M3 not only operates “m3.com”, a site run for healthcare professionals with 209,000 physician members in Japan, but also has built panels with 1.2 million physicians in the United States, Europe, China, and South Korea, and offers global survey services to medical-related businesses with a focus on pharmaceutical companies.

At this time, AIP and M3 have agreed to a capital and business alliance in order to cooperate in offering healthcare research in rapidly growing Southeast Asian countries, as well as provide survey services to global clients. With this capital and business alliance, AIP becomes an equity method affiliate of M3, and it is expected the two will create a stronger collaborative structure.

Outline of the Capital Alliance
1. Scheme
Approximately 17% of AIP’s outstanding shares from existing AIP shareholders were transferred to M3.

2. Schedule
Conclusion of agreement on transfer of shares: September 6, 2011
Transfer of shares: September 9, 2011

Outline of the Business Alliance
1. Joint construction of panels for healthcare professionals in Southeast Asia
The two companies will jointly construct healthcare professional panels and offer research services making use of appropriate panels in Southeast Asia, where concomitant with rapid economic growth, market research needs are increasing. In the future, the two companies are also planning to offer a variety of promotion services, beginning with “MR-kun,” a marketing support service designed for pharmaceutical companies, in regions where panels are constructed.

2. Collaboration in sales of M3 healthcare professional panel
AIP joint engagement in the sale of the M3 Group healthcare professional panel (including 1.2 million physicians worldwide) to global clients will propel the continued expansion of service offerings.

3. 3. Collaboration in sales of AIP’s patient panel
The sale of AIP’s patient reach, spread across more than 45 countries and regions, by M3, will foster sales synergy with the physician panel.　Moreover, promoting membership in AIP’s proprietary panels to the general consumers belonging to the M3 Group will strengthen the platform for AIP’s patient surveys and foster additional sales expansion.